malignant lymphoma

Showing 1 - 23 of 23

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

COVID-19 Infection in Malignant Lymphomas Participating in

Completed
  • Malignant Lymphoma
  • +2 more
  • No intervention
  • Guangzhou, Guangdong, China
    Department of Medical Oncology, Sun Yat-Sen University Cancer Ce
Apr 22, 2023

Malignant Lymphoma, Multiple Myeloma Trial (Pentaisomaltose)

Not yet recruiting
  • Malignant Lymphoma
  • Multiple Myeloma
  • Pentaisomaltose
  • (no location specified)
Jan 5, 2023

Acute Lymphoblastic Leukemia, Myeloblastic Leukemia, Biphenotypic Acute Leukemia Trial (GVHD prevention: post-transplantation

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +5 more
  • GVHD prevention: post-transplantation cyclophosphamide, abatacept, vedolizumab, calcineurin inhibitor
  • (no location specified)
Aug 23, 2022

Patients With Solid Tumors and Malignant Lymphoma

Completed
  • Anemia, Iron Deficiency
  • +2 more
  • non-interventional retrospective epidemiological observational study
  • Kaiserslautern, Germany
    Studienzentrum Prof. Dr. med. Hartmut Link, Facharzt für Innere
Feb 14, 2022

COVID-19 After Autologous Hematopoietic Stem Cell

Completed
  • Covid19
  • +4 more
  • Autologous stem cell transplantation
  • Uppsala, Sweden
    Uppsala Universitet
Feb 7, 2022

Acute Myeloid Leukemia, Acute Lymphoid Leukemia, MDS Trial in Leiden (MDG1021 dose 1, MDG1021 dose 2, MDG1021 dose 3)

Withdrawn
  • Acute Myeloid Leukemia
  • +7 more
  • MDG1021 dose 1
  • +3 more
  • Leiden, Zuid Holland, Netherlands
    Leiden University Medical Centre
Sep 30, 2021

Radiotherapy Side Effect, NSCLC, Esophageal Cancer Trial in Groningen (CPAP)

Recruiting
  • Radiotherapy Side Effect
  • +3 more
  • CPAP
  • Groningen, Netherlands
    University Medical Center Groningen
Jul 22, 2021

Lean Body Mass and Side Effects in Patients With Lymphoma

Recruiting
  • Malignant Lymphoma
    • Copenhagen, Frederiksberg, Denmark
    • +1 more
    Jan 4, 2021

    Malignant Lymphoma Trial in Ramat Gan (Thiotepa)

    Recruiting
    • Malignant Lymphoma
    • Ramat Gan, Israel
      Chaim Sheba Medical Center
    Oct 21, 2020

    Malignant Lymphoma Trial in Tianjin (Toripalimab)

    Completed
    • Malignant Lymphoma
    • Toripalimab
    • Tianjin, Tianjin, China
      Blood Diseases Hospital, Chinese Academy of Medical Sciences
    Sep 28, 2020

    Interest of a Systematic One-year Monitoring by 18F-FDG PET-CT

    Completed
    • Malignant Lymphoma
    • +3 more
      • (no location specified)
      Jul 8, 2020

      Hematologic Malignancy, Malignant Lymphoma Trial in Sarasota, Nashville, London (Romidepsin, Rifampin)

      Completed
      • Hematologic Malignancy
      • Malignant Lymphoma
      • Sarasota, Florida
      • +2 more
      Nov 14, 2019

      Hematologic Malignancy, Malignant Lymphoma Trial in Sarasota, Nashville, London (Romidepsin, Ketoconazole)

      Completed
      • Hematologic Malignancy
      • Malignant Lymphoma
      • Sarasota, Florida
      • +2 more
      Nov 14, 2019

      Acute Myeloid Leukemia, Acute Leukemia, Chronic Myelogenous Leukemia Trial in Chicago (fludarabine/busulfan, fludarabine/

      Completed
      • Acute Myeloid Leukemia
      • +10 more
      • Chicago, Illinois
        University of Illinois at Chicago Medical Center
      Oct 9, 2018

      Solid Tumor, Malignant Lymphoma, Tumor Trial in United States (ARQ 092)

      Completed
      • Solid Tumor
      • +2 more
      • ARQ 092
      • Birmingham, Alabama
      • +6 more
      Oct 19, 2017

      Hyperglycemia in nOn-diabetic Patients

      Unknown status
      • Cancer
      • +3 more
      • Goyang, Korea, Republic of
      • +1 more
      Apr 5, 2017

      Acute Myelogenous Leukemia, Lymphoid Leukemia, Chronic Myelogenous Leukemia Trial in Chicago (Fludarabine, Melphalan, Stem

      Completed
      • Acute Myelogenous Leukemia
      • +8 more
      • Chicago, Illinois
        The University of Chicago
      Oct 7, 2016

      Advanced Solid Malignancies, Malignant Lymphoma Trial in Chuo-ku, Manchester, Surrey (AZD1208)

      Completed
      • Advanced Solid Malignancies
      • Malignant Lymphoma
      • Chuo-ku, Japan
      • +2 more
      Oct 6, 2015

      Malignant Lymphoma Trial in Worldwide (r-metHuSCF and Filgrastim, Chemotherapy plus Filgrastim)

      Terminated
      • Malignant Lymphoma
      • r-metHuSCF and Filgrastim
      • Chemotherapy plus Filgrastim
      • Aalborg, Denmark
      • +7 more
      Jun 24, 2015

      Malignant Lymphoma Trial in Beijing (Mitoxantrone Hydrochloride Liposome)

      Unknown status
      • Malignant Lymphoma
      • Mitoxantrone Hydrochloride Liposome
      • Beijing, China
        Cancer Hospital ,Chinese Academy of Mddical Sciences
      May 4, 2014

      Hematological Diseases, Hematological Malignancies, Blood Diseases Trial in Herlev (Bismuth tablets, Placebo tablets)

      Completed
      • Hematological Diseases
      • +5 more
      • Bismuth tablets
      • Placebo tablets
      • Herlev, Denmark
        Department of Haematology L, Herlev Hospital, Herlev Ringvej 75
      Sep 9, 2013

      Whole-body Magnetic Resonance Imaging for Staging Malignant

      Completed
      • Malignant Lymphoma
      • +2 more
        • Amsterdam, Noord-Holland, Netherlands
        • +2 more
        Jul 2, 2013

        p-AKT Expression on Clinical Outcomes in Malignant Lymphoma

        Completed
        • Malignant Lymphoma
        • P13K-AKT Pathway Deregulation
        • p-AKT immunohistochemical staining
        • Seoul, Korea, Republic of
          Samsung Medical Center
        Feb 7, 2013